Symbol="FNCH"
AssetType="Common Stock"
Name="Finch Therapeutics Group Inc"
Description="Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutic company, is developing a new class of orally administered biologic drugs in the United States. The company is headquartered in Somerville, Massachusetts."
CIK="1733257"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="200 INNER BELT ROAD, SOMERVILLE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="11233800"
EBITDA="-83095000"
PERatio="None"
PEGRatio="None"
BookValue="20.57"
DividendPerShare="0"
DividendYield="0"
EPS="-99.89"
RevenuePerShareTTM="0.385"
ProfitMargin="0"
OperatingMarginTTM="-144.36"
ReturnOnAssetsTTM="-0.391"
ReturnOnEquityTTM="-1.448"
RevenueTTM="614000"
GrossProfitTTM="-57032000"
DilutedEPSTTM="-99.89"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.698"
AnalystTargetPrice="150"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="23.38"
PriceToBookRatio="0.362"
EVToRevenue="6.54"
EVToEBITDA="-0.132"
Beta="0.155"
num_52WeekHigh="87.28"
num_52WeekLow="7"
num_50DayMovingAverage="8.55"
num_200DayMovingAverage="15.45"
SharesOutstanding="1604800"
DividendDate="None"
ExDividendDate="None"
symbol="FNCH"
open="6.86"
high="6.97"
low="6.50"
price="6.50"
volume="5301.00"
latest_trading_day="2023-08-10"
previous_close="7.00"
change="-0.50"
change_percent="-7.1429%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="84"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="16"
Volume_recent_avg="192050"
Change_recent_avg="0.02"
Delta_recent_avg="0.33"
Variance_recent_avg="0.16"
Change_ratio_recent_avg="1.02"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="16"
Aroon_momentum_negative="84"
image_negative_thumbnail_id_1="162"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0014.jpeg"
image_negative_thumbnail_id_2="1118"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0151.jpeg"
image_neutral_thumbnail_id_1="586"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0013.jpeg"
image_neutral_thumbnail_id_2="560"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0039.jpeg"
image_positive_thumbnail_id_1="988"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0150.jpeg"
image_positive_thumbnail_id_2="1002"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0164.jpeg"
image_professor_thumbnail_id_1="1189"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
